27/120
1.1 / 5 stars
All 120 Win/Lose results shown below
RFL Roast Me summary
Rafael Holdings, Inc. (RFL). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
Trailing 1 year (4 quarters): 6 wins, 6 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinRFL / S&P 162.40% / 15.20% |
WinRFL / S&P 33.88% / 15.00% |
LoseRFL / S&P RFL unavailable / 50.40% |
| 2026-Q12/3 |
WinRFL / S&P 5.93% / -4.33% |
WinRFL / S&P 64.73% / 11.30% |
LoseRFL / S&P RFL unavailable / 27.70% |
| 2025-Q41/3 |
LoseRFL / S&P -13.24% / 2.65% |
WinRFL / S&P 47.63% / 9.00% |
LoseRFL / S&P RFL unavailable / 13.40% |
| 2025-Q31/3 |
LoseRFL / S&P -21.39% / 8.12% |
WinRFL / S&P 43.96% / 4.61% |
LoseRFL / S&P RFL unavailable / 13.45% |
| 2025-Q21/3 |
LoseRFL / S&P -6.19% / 10.94% |
WinRFL / S&P 35.56% / 4.83% |
LoseRFL / S&P RFL unavailable / 10.63% |
| 2025-Q12/3 |
WinRFL / S&P 13.33% / -4.27% |
WinRFL / S&P 156.73% / 4.98% |
LoseRFL / S&P -2210.00% / 10.57% |
| 2024-Q41/3 |
LoseRFL / S&P -14.95% / 2.41% |
WinRFL / S&P 151.62% / 5.25% |
LoseRFL / S&P RFL unavailable / 6.15% |
| 2024-Q32/3 |
WinRFL / S&P 34.72% / 5.89% |
WinRFL / S&P 128.32% / 5.89% |
LoseRFL / S&P RFL unavailable / 6.11% |
| 2024-Q21/3 |
LoseRFL / S&P -16.28% / 4.28% |
WinRFL / S&P 92.86% / 5.38% |
LoseRFL / S&P RFL unavailable / 5.12% |
| 2024-Q10/3 |
LoseRFL / S&P -6.01% / 10.56% |
LoseRFL / S&P -3.51% / 5.71% |
LoseRFL / S&P RFL unavailable / 5.59% |
| 2023-Q40/3 |
LoseRFL / S&P -3.68% / 11.69% |
LoseRFL / S&P -4.15% / 6.81% |
LoseRFL / S&P RFL unavailable / 7.78% |
| 2023-Q30/3 |
LoseRFL / S&P -9.09% / -3.27% |
LoseRFL / S&P -31.95% / 7.52% |
LoseRFL / S&P RFL unavailable / -5.03% |
| 2023-Q21/3 |
WinRFL / S&P 34.84% / 8.74% |
LoseRFL / S&P RFL unavailable / 9.50% |
LoseRFL / S&P RFL unavailable / -8.57% |
| 2023-Q10/3 |
LoseRFL / S&P -17.11% / 7.50% |
LoseRFL / S&P RFL unavailable / 10.77% |
LoseRFL / S&P RFL unavailable / -15.69% |
| 2022-Q40/3 |
LoseRFL / S&P 3.89% / 7.56% |
LoseRFL / S&P RFL unavailable / 11.88% |
LoseRFL / S&P RFL unavailable / -17.99% |
| 2022-Q31/3 |
WinRFL / S&P -3.74% / -4.88% |
LoseRFL / S&P -48.88% / 13.47% |
LoseRFL / S&P RFL unavailable / -1.41% |
| 2022-Q20/3 |
LoseRFL / S&P -25.50% / -16.10% |
LoseRFL / S&P -143.82% / 13.71% |
LoseRFL / S&P RFL unavailable / 11.04% |
| 2022-Q10/3 |
LoseRFL / S&P -50.78% / -4.60% |
LoseRFL / S&P -121.11% / 15.97% |
LoseRFL / S&P RFL unavailable / 42.23% |
| 2021-Q40/3 |
LoseRFL / S&P -83.40% / 11.03% |
LoseRFL / S&P -101.26% / 15.00% |
LoseRFL / S&P RFL unavailable / 96.40% |
| 2021-Q30/3 |
LoseRFL / S&P -39.80% / 0.58% |
LoseRFL / S&P -83.67% / 10.77% |
LoseRFL / S&P RFL unavailable / 69.42% |
| 2021-Q21/3 |
WinRFL / S&P 27.88% / 8.55% |
LoseRFL / S&P -16.36% / 6.58% |
LoseRFL / S&P RFL unavailable / 51.81% |
| 2021-Q11/3 |
WinRFL / S&P 71.18% / 6.17% |
LoseRFL / S&P -14.33% / -1.06% |
LoseRFL / S&P RFL unavailable / 7.39% |
| 2020-Q41/3 |
WinRFL / S&P 50.45% / 12.15% |
LoseRFL / S&P -5.05% / -3.72% |
LoseRFL / S&P RFL unavailable / -33.42% |
| 2020-Q31/3 |
LoseRFL / S&P 7.86% / 8.93% |
WinRFL / S&P -0.43% / -2.04% |
LoseRFL / S&P RFL unavailable / -27.10% |
| 2020-Q21/3 |
LoseRFL / S&P 12.18% / 20.54% |
WinRFL / S&P 6.94% / -0.46% |
LoseRFL / S&P RFL unavailable / -27.11% |
| 2020-Q11/3 |
LoseRFL / S&P -28.20% / -19.60% |
WinRFL / S&P 17.18% / 3.47% |
LoseRFL / S&P RFL unavailable / -14.75% |
| 2019-Q41/3 |
LoseRFL / S&P -14.89% / 9.07% |
WinRFL / S&P 13.82% / 5.36% |
LoseRFL / S&P RFL unavailable / 2.99% |
| 2019-Q31/3 |
LoseRFL / S&P -27.10% / 1.70% |
WinRFL / S&P 12.81% / 5.02% |
LoseRFL / S&P RFL unavailable / 0.21% |
| 2019-Q21/3 |
WinRFL / S&P 127.27% / 4.30% |
LoseRFL / S&P -0.25% / 6.64% |
LoseRFL / S&P RFL unavailable / 8.65% |
| 2019-Q11/3 |
WinRFL / S&P 59.52% / 13.65% |
LoseRFL / S&P -9.81% / 8.12% |
LoseRFL / S&P RFL unavailable / 14.29% |
| 2018-Q41/3 |
WinRFL / S&P -5.60% / -13.52% |
LoseRFL / S&P -17.41% / 9.05% |
LoseRFL / S&P RFL unavailable / 18.23% |
| 2018-Q30/3 |
LoseRFL / S&P -8.60% / 7.71% |
LoseRFL / S&P -22.20% / 10.21% |
LoseRFL / S&P -9400.00% / 19.06% |
| 2018-Q21/3 |
WinRFL / S&P 89.48% / 3.43% |
LoseRFL / S&P RFL unavailable / 9.03% |
LoseRFL / S&P RFL unavailable / 14.46% |
| 2018-Q10/3 |
LoseRFL / S&P RFL unavailable / -0.76% |
LoseRFL / S&P RFL unavailable / 7.68% |
LoseRFL / S&P RFL unavailable / 12.46% |
| 2017-Q40/3 |
LoseRFL / S&P RFL unavailable / 6.64% |
LoseRFL / S&P RFL unavailable / 7.03% |
LoseRFL / S&P RFL unavailable / 13.82% |
| 2017-Q30/3 |
LoseRFL / S&P RFL unavailable / 4.48% |
LoseRFL / S&P 0.52% / 5.68% |
LoseRFL / S&P -83.33% / 17.57% |
| 2017-Q20/3 |
LoseRFL / S&P RFL unavailable / 3.09% |
LoseRFL / S&P RFL unavailable / 4.83% |
LoseRFL / S&P RFL unavailable / 17.74% |
| 2017-Q10/3 |
LoseRFL / S&P RFL unavailable / 6.07% |
LoseRFL / S&P RFL unavailable / 3.67% |
LoseRFL / S&P RFL unavailable / 13.32% |
| 2016-Q40/3 |
LoseRFL / S&P RFL unavailable / 3.82% |
LoseRFL / S&P RFL unavailable / 2.09% |
LoseRFL / S&P RFL unavailable / 7.05% |
| 2016-Q30/3 |
LoseRFL / S&P RFL unavailable / 3.85% |
LoseRFL / S&P RFL unavailable / 0.20% |
LoseRFL / S&P RFL unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | RFL total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 67.91% | 20.78% |
| Annualized return | 67.91% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | RFL total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -93.99% | 83.14% |
| Annualized return | -43.02% | 12.86% |
10Y · 2018-03-27 to 2026-08-28
| Metric | RFL total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -48.92% | 319.30% |
| Annualized return | -6.50% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |